$1.06
-0.07[-6.19%]
At close: Apr 23
$1.06
0[0.00%]
PreMarket: 4:06AM EDT
Karyopharm Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Karyopharm Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/06/2024 | AM | KPTI | Q1 | -$0.30 | -$0.33 | — | — | $38.70M | $34.47M | — | — | Get Alert |
02/29/2024 | AM | KPTI | Q4 | -$0.43 | -$0.31 | -$0.36 | -16.13% | $33.58M | $35.40M | $33.75M | -4.67% | Get Alert |
11/02/2023 | AM | KPTI | Q3 | -$0.45 | -$0.28 | -$0.30 | -7.14% | $36.15M | $37.28M | $36.01M | -3.41% | Get Alert |
08/02/2023 | AM | KPTI | Q2 | -$0.62 | -$0.34 | -$0.29 | 14.71% | $39.68M | $36.23M | $37.58M | 3.72% | Get Alert |
05/04/2023 | AM | KPTI | Q1 | -$0.53 | -$0.37 | -$0.30 | 18.92% | $47.67M | $36.60M | $38.70M | 5.73% | Get Alert |
02/15/2023 | AM | KPTI | Q4 | $0.46 | -$0.35 | -$0.43 | -22.86% | $126.27M | $35.12M | $33.58M | -4.38% | Get Alert |
11/03/2022 | PM | KPTI | Q3 | -$0.69 | -$0.57 | -$0.45 | 21.05% | $37.69M | $34.56M | $36.15M | 4.59% | Get Alert |
08/04/2022 | AM | KPTI | Q2 | -$0.71 | -$0.63 | -$0.62 | 1.59% | $22.60M | $35.59M | $39.68M | 11.49% | Get Alert |
05/05/2022 | AM | KPTI | Q1 | -$0.77 | -$0.63 | -$0.53 | 15.87% | $23.26M | $34.17M | $47.67M | 39.51% | Get Alert |
02/08/2022 | AM | KPTI | Q4 | -$0.59 | -$0.49 | $0.46 | 193.88% | $35.10M | $50.49M | $126.27M | 150.09% | Get Alert |
11/03/2021 | AM | KPTI | Q3 | -$0.73 | -$0.67 | -$0.69 | -2.99% | $21.33M | $25.80M | $37.69M | 46.08% | Get Alert |
08/05/2021 | AM | KPTI | Q2 | -$0.63 | -$0.74 | -$0.71 | 4.05% | $33.51M | $25.64M | $22.60M | -11.85% | Get Alert |
05/03/2021 | AM | KPTI | Q1 | -$0.78 | -$0.71 | -$0.77 | -8.45% | $18.14M | $25.17M | $23.26M | -7.59% | Get Alert |
02/11/2021 | AM | KPTI | Q4 | -$0.76 | -$0.59 | -$0.59 | 0.00% | $18.10M | $29.37M | $35.10M | 19.51% | Get Alert |
11/02/2020 | PM | KPTI | Q3 | -$0.67 | -$0.72 | -$0.73 | -1.39% | $13.15M | $21.45M | $21.33M | -0.55% | Get Alert |
08/04/2020 | AM | KPTI | Q2 | -$0.71 | -$0.58 | -$0.63 | -8.62% | $9.49M | $27.42M | $33.51M | 22.22% | Get Alert |
05/05/2020 | AM | KPTI | Q1 | -$1.09 | -$0.69 | -$0.78 | -13.04% | $155.00K | $21.28M | $18.14M | -14.77% | Get Alert |
02/13/2020 | AM | KPTI | Q4 | -$0.96 | -$0.67 | -$0.76 | -13.43% | $206.00K | $16.34M | $18.10M | 10.75% | Get Alert |
11/04/2019 | AM | KPTI | Q3 | -$0.79 | -$0.84 | -$0.67 | 20.24% | $239.00K | $1.80M | $13.15M | — | Get Alert |
Karyopharm Therapeutics (KPTI) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on February 29, 2024 for Q4.
The Actual EPS was $-0.36, which missed the estimate of $-0.31.
The Actual Revenue was $33.7M, which missed the estimate of $35.4M.
Browse earnings estimates, EPS, and revenue on all stocks.